Similarly, as aberrant NF-κB activation and up-regulation of anti-apoptotic BCL2-family proteins were being clinically and experimentally implicated in poor prognosis DLBCL [5], mechanistic models of NF-κB and apoptosis were reaching maturity [34,38]. Here, NFKB1 is linked to diffuse large B-cell lymphoma.